Retrospective Study of the Effectiveness of Azithromycin Single Dose Versus One-week Doxycycline for Anorectal Chlamydia in Men Who Have Sex with Men
DOI:
https://doi.org/10.2340/00015555-3750Keywords:
Chlamydia trachomatis, MSM, doxycycline, azithromycin, HIV, lymphogranuloma venereum, anal canalAbstract
Abstract is missing (Short Communication)
Downloads
References
Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Raddad LJ, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis:global prevalence and incidence estimates, 2016. Bull World Health Organ 2019; 97: 548-562.
DOI: https://doi.org/10.2471/BLT.18.228486
Kong FYS, Tabrizi SN, Fairley CK, Vodstrcil A, Huston WM, Chen M, et al. The efficacy of azithromycin and doxycycline for the treatment of rectal chlamydia infection: a systematic review and meta-analysis. J Antimicrob Chemother 2015; 70: 1290-1297.
DOI: https://doi.org/10.1093/jac/dku574
Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64: 1-137.
Lanjouw E, Ouburg S, de Vries HJ, Stary A, Radcliffe K, Unemo M. 2015 European guideline on the management of Chlamydia trachomatis infections. Int J STD AIDS 2016; 27: 333-348.
DOI: https://doi.org/10.1177/0956462415618837
Reinton N, Moi H, Olsen AO, Zarabyan N, Bjerner J, Tønseth TM, et al. Anatomic distribution of Neisseria gonorrhoeae, Chlamydia trachomatis and Mycoplasma genitalium infections in men who have sex with men. Sexual Health 2013; 10: 199-203.
DOI: https://doi.org/10.1071/SH12092
Macaux L, Zemali N, Jaubert J, Koumar Y, Manaquin R1, Poubeau P, et al. Single dose of azithromycin for treatment of patients with asymptomatic rectal chlamydia trachomatis. Acta Derm Venereol 2020; 100: adv00313
DOI: https://doi.org/10.2340/00015555-3675
Peuchant O, Lhomme E, Krêt M, Ghezzoul B, Roussillon C, Bébéar C et al. Randomized, open-label, multicenter study of azithromycin compared with doxycycline for treating anorectal Chlamydia trachomatis infection concomitant to a vaginal infection (CHLAZIDOXY study). Medicine 2019; 98: e14572.
DOI: https://doi.org/10.1097/MD.0000000000014572
Lau A, Kong F, Fairley CK, Donovan B, Chen M, Bradshaw C, et al. Treatment efficacy of azithromycin 1 g single dose versus doxycycline 100 mg twice daily for 7 days for the treatment of rectal chlamydia among men who have sex with men - a double-blind randomised controlled trial protocol. BMC Infect Dis 2017; 17: 35.
DOI: https://doi.org/10.1186/s12879-016-2125-7
Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis 2002; 29: 497-502.
DOI: https://doi.org/10.1097/00007435-200209000-00001
Kong FY, Tabrizi SN, Fairley CK, Phillips S, Fehler G, Law M, et al. Higher organism load associated with failure of azithromycin to treat rectal chlamydia. Epidemiol Infect 2016; 144: 2587-2596.
DOI: https://doi.org/10.1017/S0950268816000996
Gladue RP, Bright GM, Isaacson RE, Newborg MF. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob Agents Chemother 1989; 33: 277-282.
DOI: https://doi.org/10.1128/AAC.33.3.277
Fuchs EJ, Lee LA, Torbenson MS, Parsons TL, Bakshi RP, Guidos AM, et al. Hyperosmolar sexual lubricant causes epithelial damage in the distal colon: potential implication for HIV transmission. J Infect Dis 2007; 195: 703-710.
DOI: https://doi.org/10.1086/511279
Haugstvedt A, Thorvaldsen J, Halsos AM. [Lymphogranuloma venerum as ulcerous proctitis in men who have sex with men]. Tidsskr Nor Laegeforen 2007; 127: 2094-2095 (in Norwegian).
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Premnaath Torayraju, Kiran Kalidindi, Usha Hartgill, Harald Moi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
